新規登録 | ログイン | FAQ      [?] 

Oncogene

最近発刊の雑誌の目次より: Oncogene © Nature Publishing Group
  • Molecular association between β-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/β-catenin signaling
    Oncogene, Vol. aop, No. current.
    by G Upadhyay, W Goessling, TE North, R Xavier, LI Zon, V Yajnik
  • Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype
    Oncogene, Vol. aop, No. current.
    by K Mazan-Mamczarz, PR Hagner, S Corl, S Srikantan, WH Wood, KG Becker, M Gorospe, JD Keene, AS Levenson, RB Gartenhaus
  • Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7
    Oncogene, Vol. aop, No. current.
    by Y Ishikawa, I Onoyama, KI Nakayama, K Nakayama
  • Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling
    Oncogene, Vol. aop, No. current.
    by LE Dow, IA Elsum, CL King, KM Kinross, HE Richardson, PO Humbert
  • RASSF1A interacts with and activates the mitotic kinase Aurora-A
    Oncogene, Vol. aop, No. current.
    by L Liu, C Guo, R Dammann, S Tommasi, GP Pfeifer
  • ABINs inhibit EGF receptor-mediated NF-κB activation and growth of EGF receptor-overexpressing tumour cells
    Oncogene, Vol. aop, No. current.
    by L Huang, L Verstrepen, K Heyninck, A Wullaert, H Revets, P De Baetselier, R Beyaert
  • Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ
    Oncogene, Vol. aop, No. current.
    by JM Brondello, MJ Pillaire, C Rodriguez, PA Gourraud, J Selves, C Cazaux, J Piette
  • A novel fusion 5′AFF3/3′BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma
    Oncogene, Vol. aop, No. current.
    by L Impera, F Albano, C Lo Cunsolo, S Funes, P Iuzzolino, F Laveder, I Panagopoulos, M Rocchi, CT Storlazzi
  • Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions
    Oncogene, Vol. aop, No. current.
    by ER Motrescu, S Blaise, N Etique, N Messaddeq, MP Chenard, I Stoll, C Tomasetto, MC Rio
  • Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
    Oncogene, Vol. aop, No. current.
    by AMS Müller, J Duque, JA Shizuru, M Lübbert
  • Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor
    Oncogene, Vol. aop, No. current.
    by K Hirose, C Abramovich, B Argiropoulos, RK Humphries
  • N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma
    Oncogene, Vol. aop, No. current.
    by MS Hossain, T Ozaki, H Wang, A Nakagawa, H Takenobu, M Ohira, T Kamijo, A Nakagawara
  • DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells
    Oncogene, Vol. aop, No. current.
    by E García-Aragoncillo, J Carrillo, E Lalli, N Agra, G Gómez-López, Pestaña, J Alonso
  • Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses β-catenin-dependent transcription
    Oncogene, Vol. aop, No. current.
    by R Fukuyama, R Niculaita, KP Ng, E Obusez, J Sanchez, M Kalady, PP Aung, G Casey, N Sizemore
  • Recruitment of adenomatous polyposis coli and β-catenin to axin-puncta
    Oncogene, Vol. aop, No. current.
    by MC Faux, JL Coates, B Catimel, S Cody, AHA Clayton, MJ Layton, AW Burgess
  • TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities
    Oncogene, Vol. aop, No. current.
    by Y Li, Chris YF Lau
  • HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
    Oncogene, Vol. aop, No. current.
    by H Korkaya, A Paulson, F Iovino, MS Wicha
  • CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
    Oncogene, Vol. aop, No. current.
    by K Bettayeb, N Oumata, A Echalier, Y Ferandin, JA Endicott, H Galons, L Meijer
  • PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia
    Oncogene, Vol. aop, No. current.
    by G Xenaki, T Ontikatze, R Rajendran, IJ Stratford, C Dive, M Krstic-Demonacos, C Demonacos
  • v-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: alteration of AU-rich element-binding proteins
    Oncogene, Vol. aop, No. current.
    by S Sobue, M Murakami, Y Banno, H Ito, A Kimura, S Gao, A Furuhata, A Takagi, T Kojima, M Suzuki, Y Nozawa, T Murate
  • Parkin as a tumor suppressor gene for hepatocellular carcinoma
    Oncogene, Vol. aop, No. current.
    by M Fujiwara, H Marusawa, HQ Wang, A Iwai, K Ikeuchi, Y Imai, A Kataoka, N Nukina, R Takahashi, T Chiba
  • Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon
    Oncogene, Vol. aop, No. current.
    by S Lukasiak, C Schiller, P Oehlschlaeger, G Schmidtke, P Krause, DF Legler, F Autschbach, P Schirmacher, K Breuhahn, M Groettrup
  • Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway
    Oncogene, Vol. aop, No. current.
    by HF Horn, KH Vousden
  • Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells
    Oncogene, Vol. aop, No. current.
    by LL Song, Y Peng, J Yun, P Rizzo, V Chaturvedi, S Weijzen, WM Kast, PJB Stone, L Santos, A Loredo, U Lendahl, G Sonenshein, B Osborne, JZ Qin, A Pannuti, BJ Nickoloff, L Miele
  • Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors
    Oncogene, Vol. aop, No. current.
    by G Manenti, G Trincucci, A Pettinicchio, E Amendola, M Scarfò, TA Dragani
  • Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival
    Oncogene, Vol. aop, No. current.
    by S Wotton, A Terry, A Kilbey, A Jenkins, P Herzyk, E Cameron, JC Neil
  • A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma
    Oncogene, Vol. aop, No. current.
    by O Ndozangue-Touriguine, M Sebbagh, D Mérino, O Micheau, J Bertoglio, J Bréard
  • Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo
    Oncogene, Vol. aop, No. current.
    by HC Suh, W Leeanansaksiri, M Ji, KD Klarmann, K Renn, J Gooya, D Smith, I Mcniece, S Lugthart, PJM Valk, R Delwel, JR Keller
  • p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc
    Oncogene, Vol. aop, No. current.
    by N Sankar, S Baluchamy, RK Kadeppagari, G Singhal, S Weitzman, B Thimmapaya
  • Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice
    Oncogene, Vol. aop, No. current.
    by T Hasegawa, A Enomoto, T Kato, K Kawai, R Miyamoto, M Jijiwa, M Ichihara, M Ishida, N Asai, Y Murakumo, K Ohara, Y Niwa, H Goto, M Takahashi
  • TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
    Oncogene, Vol. aop, No. current.
    by C Sun, A Dobi, A Mohamed, H Li, RL Thangapazham, B Furusato, S Shaheduzzaman, SH Tan, G Vaidyanathan, E Whitman, DJ Hawksworth, Y Chen, M Nau, V Patel, M Vahey, JS Gutkind, T Sreenath, G Petrovics, IA Sesterhenn, DG Mcleod, S Srivastava
  • IKK/NF-κB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors
    Oncogene, Vol. aop, No. current.
    by K Araki, K Kawauchi, N Tanaka
  • LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
    Oncogene, Vol. aop, No. current.
    by MA Stutz, DL Shattuck, MB Laederich, KL Carraway, C Sweeney
  • Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells
    Oncogene, Vol. aop, No. current.
    by T Ueki, T Nishidate, JH Park, ML Lin, A Shimo, K Hirata, Y Nakamura, T Katagiri
  • Histone H2AX is a critical factor for cellular protection against DNA alkylating agents
    Oncogene, Vol. aop, No. current.
    by JA Meador, M Zhao, Y Su, G Narayan, CR Geard, AS Balajee
  • Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling
    Oncogene, Vol. aop, No. current.
    by NM Reddy, SR Kleeberger, JH Bream, PG Fallon, TW Kensler, M Yamamoto, SP Reddy
  • Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-α transactivation
    Oncogene, Vol. aop, No. current.
    by AH Talukder, DQ Li, B Manavathi, R Kumar
  • RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo
    Oncogene, Vol. aop, No. current.
    by A Bessard, C Frémin, F Ezan, A Fautrel, L Gailhouste, G Baffet
  • E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines
    Oncogene, Vol. aop, No. current.
    by M Kitagawa, M Aonuma, SH Lee, S Fukutake, F Mccormick
  • Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells
    Oncogene, Vol. aop, No. current.
    by T Maimets, I Neganova, L Armstrong, M Lako
  • Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo
    Oncogene, Vol. aop, No. current.
    by S Umar, S Sarkar, S Cowey, P Singh
  • Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors
    Oncogene, Vol. aop, No. current.
    by W-B Ou, M-J Zhu, GD Demetri, CDM Fletcher, JA Fletcher
  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
    Oncogene, Vol. aop, No. current.
    by F Fornari, L Gramantieri, M Ferracin, A Veronese, S Sabbioni, GA Calin, GL Grazi, C Giovannini, CM Croce, L Bolondi, M Negrini
  • DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function
    Oncogene, Vol. aop, No. current.
    by A Britschgi, E Trinh, M Rizzi, M Jenal, A Ress, A Tobler, MF Fey, K Helin, MP Tschan
  • Constitutively active Rheb induces oncogenic transformation
    Oncogene, Vol. aop, No. current.
    by H Jiang, PK Vogt
  • Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins
    Oncogene, Vol. aop, No. current.
    by L Liu, L Chen, J Chung, S Huang
  • Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells
    Oncogene, Vol. aop, No. current.
    by S Veeramani, TC Yuan, FF Lin, MF Lin
  • The MYCN oncogene is a direct target of miR-34a
    Oncogene, Vol. aop, No. current.
    by JS Wei, YK Song, S Durinck, QR Chen, ATC Cheuk, P Tsang, Q Zhang, CJ Thiele, A Slack, J Shohet, J Khan
  • Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis
    Oncogene, Vol. aop, No. current.
    by A Calvo, R Catena, MS Noble, D Carbott, I Gil-Bazo, O Gonzalez-Moreno, JI Huh, R Sharp, TH Qiu, MR Anver, G Merlino, RB Dickson, MD Johnson, JE Green
  • Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters
    Oncogene, Vol. aop, No. current.
    by K Petrie, F Guidez, J Zhu, L Howell, G Owen, YP Chew, S Parks, S Waxman, J Licht, S Mittnacht, A Zelent
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/oncogene-aop

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.